Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction (LCP) Artificial Intelligence Solution on Service Utilisation, Health Economics and Patient Outcomes

NCT05389774 is registered in ClinicalTrials.gov with Nottingham University Hospitals NHS Trust as lead sponsor.

NCT NCT05389774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05389774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction (LCP) Artificial Intelligence Solution on Service Utilisation, Health Economics and Patient Outcomes
Lead sponsor
Nottingham University Hospitals NHS Trust
Phase
Observational
Overall status
Recruiting
Start date
March 23, 2023
Completion date
August 31, 2025
Enrollment
2,000 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

ai (artificial intelligence), lung cancer, pulmonary nodule, multiple, pulmonary nodule, solitary